abstract |
The present invention relates to Interleukin-1 7 ligand and receptor family members and the discovery that IL-17 receptor A and IL-17 receptor C form a heteromeric receptor complex that is biologically active. Antagonists of the IL-17RA-IL-17RB heteromeric receptor complex are 5 disclosed, as well as various methods of use. |